Dragon Jade International Ltd DGJI
Morningstar’s Analysis
1-Star Price
PREMIUM
5-Star Price
PREMIUM
Economic Moat
PREMIUM
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile
Dragon Jade International Ltd is an investment holding company. The company through its subsidiaries is involved in the business of trading of health supplement products and providing related medical and health consultancy services. Its operating segment includes Healthcare products and services (HC) and Wine Distribution (WD). The company generates maximum revenue from the Wine Distribution (WD) segment. The firm has a business network across Asia including Hong Kong, China, Taiwan, Japan, Korea, Singapore, Malaysia, and Thailand.
Hong Kong, Virgin Islands, British